- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Højrisiko lokaliseret prostatakræft in China
I alt 410 resultater
-
The First Affiliated Hospital of Xiamen UniversityRekrutteringMetastatisk kastrationsresistent prostatakræft, mCRPCKina
-
Fudan UniversityUkendtProstatakræft MetastatiskKina
-
Shanghai Junshi Bioscience Co., Ltd.UkendtCOVID-19; og høj infektionsrisiko for SARS-CoV-2Kina
-
Affiliated Hospital to Academy of Military Medical...UkendtDCs-vaccine kombineret med cytokininducerede dræberceller hos patienter med højrisiko bløddelssarkomHøjrisiko blødt vævssarkomKina
-
Shanghai Jiao Tong University School of MedicineFudan University; Qilu Hospital of Shandong UniversityRekruttering
-
Lei LiUkendtLivmoderhalskræft | Cervikal intraepitelial neoplasi | DNA-methylering | Cytologi | Højrisiko humant papillomavirusKina
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RekrutteringKemoterapi effekt | DNA-skade reparationsmangel | Kemoterapeutisk toksicitet | Hormonfølsom metastatisk prostatakræftKina
-
Jiangsu HengRui Medicine Co., Ltd.AfsluttetHormonfølsom prostatakræftKina
-
RenJi HospitalChanghai Hospital; Peking University People's Hospital; Shanghai Zhongshan... og andre samarbejdspartnereRekruttering
-
Shanghai General Hospital, Shanghai Jiao Tong University...NanoMab Technology (UK) LimitedAfsluttet
-
Tianjin Medical University Second HospitalUkendt
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Ukendt
-
Xinhua Hospital, Shanghai Jiao Tong University...Ukendt
-
West China HospitalRekrutteringKemoradioterapi | Total Neoadjuverende behandling | Local Advanced Rectal Cancer | High Risk FactorsKina
-
Luye Pharma Group Ltd.Ikke rekrutterer endnu
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Peking Union Medical College HospitalRekruttering
-
Tianjin Medical University Second HospitalTianjin Medical University General Hospital; Tianjin First Central Hospital og andre samarbejdspartnereIkke rekrutterer endnu
-
Luye Pharma Group Ltd.Afsluttet
-
Fudan UniversityAktiv, ikke rekrutterende
-
Second Military Medical UniversityPeking Union Medical College Hospital; RenJi Hospital; Zhejiang UniversityUkendt
-
Second Military Medical UniversityAfsluttet
-
Ferring PharmaceuticalsAfsluttet
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)Ukendt
-
The First Affiliated Hospital of Soochow UniversityRekrutteringHøjrisiko Akut Myeloid Leukæmi | Mellemrisiko Akut Myeloid LeukæmiKina
-
The First Affiliated Hospital with Nanjing Medical...RekrutteringMetastatisk prostatakræft | Terapi, direkte observeretKina
-
Merck Sharp & Dohme LLCOrion Corporation, Orion PharmaRekrutteringProstatiske neoplasmer | Metastatisk kastrationsresistent prostatakræftKina
-
Shanghai East HospitalRekruttering
-
Fudan UniversityRekruttering
-
Shanghai East HospitalIkke rekrutterer endnu
-
Peking Union Medical College HospitalRekruttering
-
Shanghai East HospitalIkke rekrutterer endnu
-
Luye Pharma Group Ltd.Afsluttet
-
First Affiliated Hospital Xi'an Jiaotong UniversityRekruttering
-
First Affiliated Hospital Xi'an Jiaotong UniversityIkke rekrutterer endnu
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...First Affiliated Hospital of Zhejiang University; The First Affiliated...Rekruttering
-
Qilu Hospital of Shandong UniversityZibo Central HospitalRekruttering
-
Xiangya Hospital of Central South UniversityRekruttering
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Rekruttering
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...Ukendt
-
Lee's Pharmaceutical LimitedUkendt
-
Third Affiliated Hospital, Sun Yat-Sen UniversityUkendt
-
The First Affiliated Hospital with Nanjing Medical...RekrutteringMetastatisk prostatakræft | Intermiterende anti-androgen terapiKina
-
BayerAfsluttetKnoglemetastaser | Metastatisk kastrationsresistent prostatakræftKina
-
Changhai HospitalRekruttering
-
Xinhua Hospital, Shanghai Jiao Tong University...Rekruttering
-
Jiangsu HengRui Medicine Co., Ltd.Tilmelding efter invitationHormonreceptor positiv, human epidermal receptor 2 negativ, knudepositiv, høj risiko, tidligt stadium, brystkræft hos kvinderKina